The HIF-1A Pro582Ser polymorphism confers resistance to hyperglycaemia-mediated inhibition of HIF-1 activity and protects against the development of diabetic nephropathy, severe diabetic retinopathy and diabetic foot ulcers [7, 31, 47]. Here, HIF1A is linked to diabetic kidney disease.